Appendix B: Flowchart - hCG Stimulation And Release And Pge2 Synthesis

 Appendix B: Flowchart - hCG Stimulation And Release And Pge2 Synthesis



Appendix B

REFERENCES - Flowchart: HCG stimulation and release and PGE2 synthesis. 


1. Li Y, Matsuzaki N, Masuhiro K, Kamenda T, Taniguchi T, Saji F, Yowe K, Tanizawa 0. Trophoblast derived tumor necrosis factor-alpha induces release of human chorionic gonadotrophin using Interleukin-6 (IL-6) and IL-6 receptor dependent system in the normal human trophoblast.
J Clin Endocrinol Metab. 1992; 74; 184-191.

2. Yagel S, Lala P K, Powell W A, Casper R F.
Interleukin-1 stimulates human chorionic gonadotrophin secretion by first trimester human trophoblast.
J Clin Endocrinol Metab. 1989; 68; 992-995.

3. Nishano E, Matsuzaki N, Masuhiro K, Kameda T, Taniguchi T, Takagi T, Saji F, Tanizawa 0. Trophoblast-derived Interleukin-6 (IL-6) regulates human chorionic gonadotrophin release through IL-6 receptor on human trophoblast.
J Clin Endocrinol Metab. 1990; 71; 436-441.

4. Wahl S M, Hunt D A, Wong H L, Dougherty S, McCartney-Francis N, Wahl L M, Ellingsworth L, Schmidt J A, Hall G, Roberts A B, Sporn M B.
Transforming growth factor-B is a potent immunosuppressive agent that inhibits IL-1 dependent lymphocyte proliferation.
J Immunol. 1988; 140; 3026-3032.

5. Matsuzaki N, Li Y, Masuhiro K, Jo T, Shimoya K, Taniguchi T, Saji F, Tanizawa O.
Trophoblast-derived transforming growth factor-B suppresses cytokine induced, but not gonadotrophin releasing hormone induced, release of human chorionic gonadotrophin by normal human trophoblast.
J Clin Endocrinol Metab. 1992; 74; 211-216.

6. Graham C H, Lala P K.
Mechanism of control of trophoblast invasion in situ.
J Cell Physiol. 1991; 148; 228-234.

7. Wahl S M, Costa G L, Corcoran M, Wahl L M, Berger A E.
Transforming growth factor-B mediates IL-1 dependent induction of IL-1 receptor antagonist.
J Immunol. 1993; 150; 3553-3560.

8. Librach C L, Feigenbaum S L, Bass KE, Cui T-Y, Verastas N, Sadovsky Y, Quigley J P,
French D L, Fisher S J.
Interleukin-1B regulates human cytotrophoblast metalloproteinase activity and invasion in vitro.
J Biol Chem. 1994; 269(25); 17125-17131.

9. Kauma S, Matt D, Strom S, Aierman D, Turner T.
Interleukin-1B, human leukocyte antigen, HLA-RA gamma and transforming growth factor-B expression in endometrium, placenta and placental membranes.
Am J Obstet Gynecol. 1990; 163; 1430-1437.

10. Steele G L, Currie W D, Leung E H, Yuen B O, Leung PCK.
Rapid stimulation of human chorionic gonadotrophin secretion by interleukin-1B from perfused first trimester trophoblast.
J Clin Endocrinol Metab. 1992; 75; 783-788.

11. Masuhiro K, Matsuzaki N, Nishino E, Taniguchi T, Kameda T, Li Y, Saji F, Tanizawa O. Trophoblast-derived Interleukin-1 (IL-1) stimulates release of human chorionic gonadotrophin by activating IL-6 and IL-6 receptor system in first trimester human trophblast.
J Clin Endocrinol Metab. 1991; 72; 594-601.

12. Shimonovitz S, Yagel S, Anteby E, Finci-Yeheskel Z, Adashi E Y, Mayer M, Hurwitz A. Interleukin-1 stimulated prostaglandins-E production by human trophoblast cells from first and third trimesters.
J Clin Endocrinol Metab. 1995; 80; 1641-1646.

13. North R A, Whitehead R, Larkins R G.
Stimulation by human chorionic gonadotrophin of progstaglandin synthesis by early human placental tissue.
J Clin Endocrinol Metab. 1991; 73; 60-70.

14. Schafer A, Pauli G, Friedmann W, Dudenhausen T W.
Human chorionic gonadotrophin (HCG) and placental lactogen (hPL) inhibit Interleukin-2 (IL-2) and increase Interleukin-1B (IL-1B), Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFa) expression in monocyte cell cultures.
J Perinat Med. 1992; 20; 233-240.

15. Chouaib S, Welte K, Mertelsmann R, Dupont B.
Prostaglandin-E2 acts at two distinct pathways of T lymphocyte activation: inhibition of Interleukin-2 production and down-regulation of transferring receptor expression.
J Immunol. 1985; 135(2); 1172-1179.


16. Romero R, Mazor M, Wu Y K, Avila C, Oyarzun E, Mitchell M D.
Bacterial endotoxin and TNFa stimulated prostaglanding production by human decidua. Prostaglandins Leukotrines and Essential Fatty Acids. 1989; 37; 183-186.

17. Lala P K, Kennedy T G, Parhar R S.
Suppression of lymphocyte alloreactivity by early gestational human decidua. II. Characterisation of the suppressor mechanisms.
Cell Immunol. 1988; 116; 411-422.

18. Duchesne M J, Thaler-Dao H, Crastes de Paulet A.
Prostaglandins in human placenta and foetal membranes.
Prostaglandins. 1978; 15(1); 19-42.

19. Hirata F, Notsun Y, Inata M, Parenta L, Dirosa M, Fowler R J.
Identification of several species of phospholipase inhibitory proteins by radio-immunoassay for lipomodulin.
Biochem Biophys Research Communications. 1982; 109(1); 223-230.

20. Karim S M, Filshie G M.
Use of prostaglandin-E2 for therapeutic abortion.
BMJ. 1970; 3; 198-200.

21. Gillett R G, Kinch R A H.
Therapeutic abortion with the use of prostaglandin-F2a.
Am J Obstet Gynecol. 1972; 112; 330-338.

22. Wiqvist W, Bygdeman H.
Induction of therapeutic abortion with IV prostaglandin-F2a.
Lancet. 1970; 1; 889.

23. Karim S M.
Second trimester abortion with single intra-amniotic injection of prostaglandin-E2 or F2a.
Lancet. 1971; 11; 47-48.

24. Gillett P G, Kinch RAW, Wolfe L S, Pace Asciak C.
In; Prostalgandins clinical applications to human reproduction.
Ed. Southern, p 373-380. Futura Publishing Company, New York, 1972.

25. Shapiro A G.
Extra-ovular prostaglandin-F2a for early mid trimester abortion.
Am J Obstet Gynecol. 1975; 121(3); 333-336.

26. Emery M P, Hillier K.
In; Prostalgandins clinical applications to human reproduction.
Ed. Southern, p 381. Futura Publishing Company, New York, 1972.

27. Karim SMM, Hillier K, Trussell P.
Induction of labour with prostaglandin-E2.
J Obstet Gynaecol Brit Commonwealth. 1970; 77; 200-210.

28. Beazley J M, Dewhurt C T, Gillespie A.
Induction of labour with prostaglandin-E2.
J Obstet Gynaecol Brit Commonwealth. 1970; 77; 193-199.

29. Wiqvist M, Beguim P, Bygdeman M, Toppozada M.
In; Prostalgandins clinical applications to human reproduction.
Ed. Southern, p 293. Futura Publishing Company, New York, 1972.

30. Jewelewicz R, Cantor B, Dyrenfirth I.
Intravenous infusion of PGF2a in the mid luteal phase of the normal human menstrual cycle.
Prostaglandins. 1972; 1; 443-

31. Lysiak J J, Hunt J, Pringle G A, Lala P K.
Localisation of transforming growth factor-B1 and its natural inhibitor decorin in the human placenta and decidua throughout gestation.
Placenta. 1995; 16; 221-231.
32. Lala P K, Al-Mutter N.
Suppression of NK and LAK cell activity of human peripheral blood leukocytes by TGFB is in part mediated by induction of prostaglandins.
Proceedings of the Canadian Federation of Federal Biological Societies. 1992; 35; 79.

33. Fujisaki S, Kawano K, Haruyama Y, Mori N.
Synergistic effect of progesterone on prostaglandin-E modulation of the mytogenic response of human peripheral blood lymphocytes.
J Reprod Immunol. 1985; 7; 15-26.

34. Lala P K, Parhar H R, Kearns M, Johnson S, Scodras J M.
Immunological aspects of the decidual response.
In: Reproductive Immunology. 1986. Eds Clark D A, Croy B A. Elsevier Science Publishers BV (Biochemical Division)

35. Loke Y W, King A, Burrows T D.
Decidua in human implantation.
Human Reprod. 1995; 10(2); 14-21.

36. Cheng L, Kelly W R, Thong K J, Hulme R, Baird D T.
The effects of mifepristone (RU 486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy.
Human Reprod. 1993: 8(5); 705-709.

37. Falkay G, Sas M.
Correlation between the concentrations of prostaglanding dehydrogenase and progesterone in the early human placenta.
J Endocrinol. 1978; 76; 173-174.

38. Cheng L, Kelly W R, Thong K J, Hulme R, Baird D T.
The effects of mifepristone (RU 486) on the immunohistochemical distribution of prostaglandin-E and its metabolite in decidual and chorionic tissue in early pregnancy.
J Clin Endocrinol Metab. 1993; 77; 873-877.

39. Stites D P, Bugbee S, Siiteri P K.
Differential actions of progesterone and cortisol and leukocyte and monocyte interaction during lymphocyte activation: relevance of immunosuppression in pregnancy.
J Reprod Immunol. 1993; 5; 215-228.

40. Peterson R E.
In: Endocrinology of Pregnancy, p 164-165. Eds Fuchs F, Klopper A.
Second edition, Harper and Row.

41. Maruo T, Matsuo H, Murata K, Mochizuki M.
Gestational age-dependent dual action of epidermal growth factor in human placenta early in gestation.
J Clin Endocrinol Metab. 1992; 75(5); 136-137.

42. Barnea E R, Feldman D, Kaplan M, Morrish D W.
The dual effect of epidermal growth factor upon HCG secretion by the first trimester placenta early in gestation.
J Clin Endocrinol Metab. 1990; 71(4); 923-928.

43. Cheng Chu-Fung, Kurachi H, Fujita Y, Terakana N, Miyake A, Tanizawa O.
Changes in epidermal growth factor receptor and its messenger ribonucleic acid levels in human placenta and isolated trophoblast cells during pregnancy.
J Clin Endocrinol Metab. 1988; 67; 1171-1177.

44. Hussa ROM, Story T, Pattillo R A.
Cyclic adenosing monophosphate stimulated secretion of human chorionic gonadotrophin and oestrogens by human trophoblast in vitro.
J Clin Endocrinol Metab. 1974; 38; 338.

45. Handwerger S, Barrett J, Tyney L, Schonberg D.
Differential effect of cyclic adenosing monophosphate on the secretion of human placental lactogen and human chorionic gonadotrophin.
J Clin Endocrinol Metab. 1973; 36; 1268-1270

46. Whitsett J A, Johnson C L, Noguchi A, Davorec-Beckerman C, Costello M.
Beta adrenergic receptors, and catecholamine sensitive adenylate cyclase of the human placenta.
J Clin Endocrinol Metab. 1980; 50; 27-32.

47. Falkay G, Kovacs L.
Beta adrenergic receptors in early human placenta. Characterisation of 3H-Dihydro- alprenolol binding.
Life Sciences. 1983; 32; 1583-1590.

48. Sharma S C, Rao A J.
Role of calcium in secretion of chorionic gonadotrophin by first trimester human placenta.
Indian J Experimental Biol. 1992; 30(11); 1105-1110.

49. Goldman A S, Baker L, Piddington R, Mark B, Herold R, Egler J.
Hyperglycaemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid.
Proc Natal Acad Sci (USA). 1985; 82; 8227-8231.

50. Le J, Vileek J.
Biology of disease - Tumour necrosis factor and interleukin-1: cytokines with multiple overlapping biological activities.
Lab Invest. 1987; 56(3); 234-246.

51. Dudley D J, Chen-Chih-Li, Murray D, Mitchell D, Daynes R A, Araneo B A.
Adapive immune responses during murine pregnancy: pregnancy-induced regulation of lymphokine production by activated T lymphocytes.
Am J Obstet Gynecol. 1993; 168; 1155-1163.

52. Kelly R W, Carr G G, Elliott C L, Tulppala M, Critchley HOD.
Prostaglanding and cytokine release by trophoblastic villi.
Human Reprod. 1995; 3289-3292.

53. Sharp B M, Matta S G, Peterson P K, Newton R, Chao C, McAllen K.
Tumor necrosis factor-alpha is a potent ACTH secretagogue: comparison to
Endocrinol. 1989; 124(6); 3131-3133.

54. Haimovici F, Anderson D J.
Cytokines and growth factors in implantation.
Microscopy Research and Technique. 1993; 25; 201-207.

55. Saito S, Saito M, Enomoto M, Ito A, Motoyoshi K, Nakagawa T, Ichito M.
Human macrophage colony-stimulating factor induced the differentiation of trophoblast.
Growth Factors. 1993; 9; 11-19.

56. Jokhi P P, Chumbley G, King A, Gardner L, Loke Y W.
Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface.
Lab Invest. 1993; 68(3); 308-320.

57. Saito S, Motoyoshi K, Ichito M, Saito M, Takaku F.
High serum human macrophage colony-stimulating factor level during pregnancy.
International J Haemtol. 1992; 55; 219-225.

58. Corcoran M L, Kibbey M C, Kleinman H K, Wahl L M.
Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin-E2 and matrix metalloproteinases.
J Biol Chem. 1995; 270(18); 10365-10368.

59. Parhar R S, Kennedy T G, Lala P K.
Suppression of lymphocyte alloreactivity by early gestional decidua.
1. Characterisation of suppressor cells and suppressor molecules.
2. Cell Immunol. 1988; 116; 392-410.

60. Parher R S, Yagel S, Lala P K.
PGE-2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity.
Cell Immunol. 1989; 120; 61-74.

61. Kuland J I, Pelus L M, Ralph P, Bockman R S, Moore MAS.
Induction of prostaglandin-E synthesis in normal and neoplastic macrophages. Role of colonoy-stimulating factor(s) distinct from effects of myeloid progenitor proliferation.
Proc Natal Acad Sci (USA). 1979; 76(5); 2326-2330.

62. Johnson R D, Walsh S W, Everson W B, Nelson D M.
Differentiation and growth on a fibrin matrix modulate the cyto-oxygenase expression and thromboxane production by cultured human placental trophoblast.
Prostaglandins Leukotrines and Essential Fatty Acids. 1995; 52; 21-27.

63. Smith S K, Kelly R W.
The release of PGF-2 and PGE-2 from separated cells of human endometrium and decidua.
Prostaglandins Leukotrines and Essential Fatty Acids. 1988; 33; 91-96.

64. Pattillo R A, Hussa R O, Story M T, Mattingly R F.
Absence of prostaglanding synthesis in the malignant human trophoblast and culture.
Am J Obstet Gynecol. 1973; 113(1); 91-94.

65. Dinarello C A.
Biology of Interleukin-1.
FASEB J. 1988; 2; 108-115.

66. Bachwich P R, Chensue W, Larrick J W, Kunkel S L.
Tumor necrosis factor stimulates interleukin-1 and prostaglandin-E2 production in resting macrophages.
Biochem Biophys Research Communication. 1986; 136(1); 94-101.

67. Garcia-Lloret M, Guilbert L, Morrish D W.
Functional expression of CSF-1 receptors on normal human cytotrophoblast.
Placenta. 1989; 10; 499-500.

68. Haynes M K, Jackson L G, Tuan R S, Shepley K J, Smith B J.
Cytokine production in first trimester chorionic villi; detection of mRNA's and protein products in situ.
Cell Immunol. 1993; 151; 300-308.

69. Burrows T D, King A, Loke Y W.
Trophoblast migration during human placental implantation.
Human Reprod Update. 1996; 2(4); 307-321.

70. Berkowitz R S, Goldstien D P, DuBeshtar B, Bernstein M R.
Management of complete molar pregnancy.
J Reprod Med. 1987; 32(9); 634-639.

71. Soto-Wright V, Bernstein M, Goldstein D P, Berkowitze R S.
The changing clinical presentation of complete molar pregnancy.
Obstet Gynaecol. 1995; 86; 775-779.

72. Sill P R, Aimo J Y, Murthy D P.
Gestational trophoblastic disease in Port Moresby, Papua New Guinea.
Aust NZ J Obstet Gynaecol. 1987; 27; 49-52.

73. Panduro Barton J G, Lagos Trujillo J, Gonzalez Hernandez A G,
Amezcua Guevara G. Cases of hydatidiform mole at the Nuevo Hospital Civil in Guadalajara. Gynaecologica Obstetrica de Mexico. 1994; 62; 197-200.

74. Zvandasara P.
Hydatidiform mole: a study of forty patients admitted at Harare Central Hospital, Zimbabwe.
Central African Journal of Medicine. 1995; 41(2); 44-48.

75. Curry S L, Hammond C D, Tyrey L, Creasman W T, Parker R T.
Hydatidiform mole: diagnosis, management and long term follow-up of 347 patients.
Obstet Gynaecol. 1975; 45(1); 1-8.

76. Douglas G W.
The diagnosis and management of hydatidiform mole.
Surg Clin N America. 1939; 37; 379-392.

77. Kauppila A, Huhtaniemi I, Ylikorkala O.
Raised serum human chorionic gonadotrophin concentrations in hyperemesis gravidarum.
BMJ. 1979; 1; 1670-1671.

78. Personal communication, 10.4.1995. Professor Bagshawe KD.




"If it wasn't for the helpline I wouldn't have got the help and the treatment I needed to cope."

Did you know?

10% of sufferers terminate otherwise wanted pregnancies because of HG.


You are not alone

If you think you are suffering from HG please call us for support on: 024 7638 2020
Latest tweet

Latest tweet

We are excited to announce Pregnancy Sickness Support's brand new fundraising initiative for 2019...…

09:29 17th February


"The helpline is a very compassionate service."

Pregnancy Sickness Support

Volunteer log-in

Pregnancy Sickness Support

Become a volunteer                 Forgot password?